Skip to main content
. Author manuscript; available in PMC: 2012 Aug 2.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Mar 4;66(6):1087–1093. doi: 10.1007/s00280-010-1266-4

Fig. 1.

Fig. 1

a Best response by RECIST to hepatic arterial infusion of cisplatin and intravenous doxil in 24 patients evaluable for response. Each red box indicates a patient with maximum response a partial response (≥30% reduction in tumor size) (n = 4), each blue box indicates a patient with stable disease (maximum response between 29% reduction in tumor size to increase by 19% in tumor size) (n = 11) and each black box indicates a patient with progressive disease (≥20% increase in tumor size) (n = 9). b Kaplan–Meier plot for overall survival. c Kaplan–Meier plot for progression-free survival